J.R. Woodburn

Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

Andrew Barker, Keith H. Gibson, Walter Grundy et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 559 citations · Full text

Molecular Pharmacology, Drug Targeting, Oncology +10

ICI 176,334: A NOVEL NON–STEROIDAL, PERIPHERALLY SELECTIVE ANTIANDROGEN

B. Valcaccia, J.R. Woodburn, Howard Tucker · Journal of Endocrinology · 1987 · 129 citations

EFFECT OF SOME TRIPHENYLETHYLENES ON OESTRADIOL BINDING IN VITRO TO MACROMOLECULES FROM UTERUS AND ANTERIOR PITUITARY

Joanne C Skidmore, A. L. WALPOLE, J.R. Woodburn · Journal of Endocrinology · 1972 · 114 citations

Endocrine Disruptors, Fertility, Endocrine Mechanism +15

ZD1839, AN EPIDERMAL GROWTH FACTOR TYROSINE KINASE INHIBITOR SELECTED FOR CLINICAL DEVELOPMENT

J.R. Woodburn, Andrew Barker, Keith H. Gibson et al. · Journal of Immunotherapy · 1997 · 66 citations

Novel Therapy, Medicine, Theatre +14

Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumour activity of novel quinazolines

Keith H. Gibson, Walter Grundy, Andrew A. Godfrey et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 55 citations

Signaling Pathway, Medicine, Receptor Tyrosine Kinase +9